Moderna Inc. (MRNA)
NASDAQ: MRNA
· Real-Time Price · USD
24.82
1.17 (4.95%)
At close: May 16, 2025, 3:59 PM
24.55
-1.09%
After-hours: May 16, 2025, 07:59 PM EDT
Moderna Revenue Breakdown
| Period Ending | Dec 31, 2024 |
|---|---|
| Collaboration Arrangement Revenue | 12M |
| Collaboration Arrangement Revenue Growth | n/a |
| Grant Revenue | 37M |
| Grant Revenue Growth | n/a |
| Product Sales Revenue | 4.52B |
| Product Sales Revenue Growth | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 212M | 351M | 281M | 268M | 274M | 470M | 442M | 332M | 305M | 375M | 278M | 211M | 268M | 201M | 168M | 121M | 77M | 78.99M | 48.54M | 36.62M | 24.11M | 25.86M | 28.19M | 28.52M | 27.28M | 38.02M | 18.52M | 21.39M | 16.32M | 15.9M | 16.73M | 16.04M | 16.04M |
| Selling, General, and Administrative Revenue Growth | -39.60% | +24.91% | +4.85% | -2.19% | -41.70% | +6.33% | +33.13% | +8.85% | -18.67% | +34.89% | +31.75% | -21.27% | +33.33% | +19.64% | +38.84% | +57.14% | -2.52% | +62.73% | +32.55% | +51.87% | -6.74% | -8.27% | -1.17% | +4.54% | -28.25% | +105.25% | -13.38% | +31.07% | +2.59% | -4.93% | +4.28% | 0.00% | n/a |
| Research and Development Revenue | 856M | 1.12B | 1.14B | 1.18B | 1.03B | 1.41B | 1.16B | 1.15B | 1.13B | 1.21B | 820M | 710M | 554M | 648M | 521M | 421M | 401M | 758.86M | 344.49M | 151.86M | 115.14M | 118.75M | 119.72M | 128.5M | 130.57M | 150.43M | 109.05M | 104.48M | 90.12M | 117.83M | 93.61M | 99.51M | 99.51M |
| Research and Development Revenue Growth | -23.71% | -1.32% | -3.64% | +14.90% | -26.96% | +21.21% | +1.05% | +1.50% | -6.61% | +47.68% | +15.49% | +28.16% | -14.51% | +24.38% | +23.75% | +4.99% | -47.16% | +120.29% | +126.85% | +31.89% | -3.05% | -0.80% | -6.83% | -1.59% | -13.20% | +37.94% | +4.38% | +15.93% | -23.51% | +25.87% | -5.93% | 0.00% | n/a |